Sanofi asks US court to halt diabetes drug patent fight with Mylan Medical Dialogues Bureau12 Feb 2020 10:30 AM IST In a stay application filed on Friday, Sanofi said a recent U.S. Court of Appeals for the Federal Circuit decision upholding the invalidation of two...
Coronavirus in China cause of concern for Indian Pharma Sector Farhat Nasim10 Feb 2020 8:03 PM ISTNew Delhi: Indian pharma firms are closely monitoring the outbreak of coronavirus in China as it could impact the supply of active pharmaceutical...
Lupin gets USFDA nod for generic version of Arava Tablets Medical Dialogues Bureau6 Feb 2020 1:08 PM IST Leflunomide Tablets USP is a generic equivalent of Arava Tablets, 10 mg and 20 mg, of Sanofi- Aventis, Lupin said.Mumbai: Pharma major Lupin Limited...
Sanofi being probed over birth defects related to Epilepsy drug Depakine Medical Dialogues Bureau5 Feb 2020 3:35 PM IST The Paris prosecutor had already launched a preliminary investigation into the authorisation and marketing of Depakine in 2016, after France's...
Sanofi Completes Acquisition of Synthorx Medical Dialogues Bureau25 Jan 2020 12:19 PM ISTPARIS- Sanofi has announced the successful completion of its acquisition of Synthorx, Inc. for $68 per share in cash. "The acquisition of...
More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs Medical Dialogues Bureau2 Jan 2020 2:48 PM ISTNew Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA Medical Dialogues Bureau2 Nov 2019 9:30 AM ISTZantac sold over-the-counter in the United States by French drugmaker Sanofi SA, and some of its generic versions, have been recalled due to possible...
Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent Medical Dialogues Bureau1 Nov 2019 3:29 PM ISTScale-up of affordable Rifapentine stands to benefit over a million people in India alone, where more people suffer from TB than anywhere else in the...
No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA Medical Dialogues Bureau24 Oct 2019 9:20 AM ISTEarly tests of alternatives to over-the-counter ranitidine, such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec show no NDMA, the agency said.New...
Sanofi pulls popular heartburn drug Zantac in US, Canada Medical Dialogues Bureau21 Oct 2019 9:30 AM ISTIn September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and...
Sanofi opens digital biologics manufacturing facility in US Farhat Nasim16 Oct 2019 9:45 AM ISTThe facility in Framingham accelerates the recent transformation of Sanofi's Industrial Affairs organization to focus on biologics-based therapies, in...
Diabetes Management: Sanofi, Abbott team up to integrate glucose sensing, insulin delivery technologies Farhat Nasim16 Sept 2019 9:30 AM ISTSanofi and Abbott will take an approach to connected care by developing tools that combine the revolutionary FreeStyle Libre technology with insulin...
